RB1 and large cell neuroendocrine carcinoma: Studies have shown that LCNEC can be further divided into SCLC-like with TP53/RB1 inactivation and NSCLC-like with retained TP53/RB1 functions, with different chemotherapy treatment results (Derks et al., 2018).